海带中岩藻黄素异构体的分离纯化及其体外抗肿瘤活性研究

海带采用乙醇提取色素,通过柱层析分离纯化其中的岩藻黄素,并最终通过高效制备液相色谱制备了三种岩藻黄素的异构体。通过紫外光谱(UV)、核磁共振氢谱(1H-NMR)以及质谱(MS)对岩藻黄素及其异构体进行了结构表征和鉴定。采用乳腺癌细胞MDA-MB-231模型,对岩藻黄素的体外抗肿瘤活性进行了研究。结果表明,岩藻黄素对乳腺癌细胞生长有显著的抑制作用,其中13-顺和13′-顺岩藻黄素组分对癌细胞的抑制活性最强, IC50值达到23.71μg/mL。全反式岩藻黄素和9′-顺岩藻黄素两种异构体IC50值分别为45.30和27.09μg/mL。qPCR试验表明岩藻黄素各异构体可以通过抑制癌细胞NF-κB家族基因表达而抑制乳腺癌细胞生长。     

文蛤多肽的体外抗癌活性研究

采用硫酸铵沉淀、有机溶剂分离、Sephadex G-25分子筛层析等实验方法,从文蛤肉中提取了一种低分子量的多肽,命名为Mer2．本文以溴化二苯偶氮盐（MTT）法检测Mer2对体外培养的癌细胞的抑制作用．结果表明Mer2对体外培养的人肝癌细胞株（HepG2）、宫颈癌细胞株（Hela）、胆管癌细胞株（QBC939）、肺癌细胞株（SPC—A-1和LTEP—a-2）的生长均有很强的抑制作用,且抑制效果随着Mer2含量的增高和处理时间的延长而增强,证明Mer2具有广谱的抗癌活性．其中Mer2对人肝癌HepG2细胞株抑制作用最为显著,光学显微镜观察经Mer2细胞培养液处理后的细胞形态发生明显的改变,流式细胞仪实验的结果表明处理后的细胞周期发生明显的改变,并在G0／G1期前出现凋亡峰．     

海绵微生物的分离培养及一种活性代谢产物的初步研究

研究海绵来源真菌Aspergillus repens发酵产物中的活性代谢产物.分离培养微生物进行活性筛选,采用活性追踪的方法、利用色谱手段分离获得单体化合物,根据波谱分析及其理化性质确定其结构,利用SRB评价单体化合物的抗肿瘤活性,利用纸片法测定单体化合物的抗植物病菌活性.获得1个萘并吡喃酮化合物,其结构鉴定为3,4-二氢-9,10-二羟基-7-甲氧基-3-甲基-1H-萘并[2,3c]吡喃-1-酮 (Semivioxanthin).该化合物对肿瘤细胞A-549、HL-60和BEL-7402有一定抑制作用,对植物致病菌作用较强.海绵微生物代谢产物是发现活性物质重要资源,值得深入研究.     

The antitumor effect of bromophenol derivatives <Emphasis Type="Italic">in vitro</Emphasis> and <Emphasis Type="Italic">Leathesia nana</Emphasis> extract <Emphasis Type="Italic">in vivo</Emphasis>

To investigate the antitumor effect of bromophenol derivatives in vitro and Leathesia nana extract in vivo, six bromophenol derivatives 6-(2,3-dibromo-4,5-dihydroxybenzyl)-2,3-dibromo-4,5-dihydroxy benzyl methyl ether (1), (+)-3-(2,3-dibromo-4,5-dihydroxyphenyl)-4-bromo-5,6-dihydroxy-1,3-dihydroisobenzofuran (2), 3-bromo-4-(2,3-dibromo-4,5-dihydroxybenzyl)-5-methoxymethyl-pyrocatechol (3), 2,2′,3,3′-tetrabromo-4,4′,5,5′-tetrahydroxy-diphenylmethane (4), bis(2,3-dibromo-4,5-dihydroxybenzyl) ether (5), 2,2′,3-tribromo-3′,4,4′,5-tetrahydroxy-6′-ethyloxymethyldiphenylmethane (6) were isolated from brown alga Leathesia nana, and their cytotoxicity were tested by MTT assays in human cancer cell lines A549, BGC-823, MCF-7, B16-BL6, HT-1080, A2780, Bel7402 and HCT-8. Their inhibitory activity against protein tyrosine kinase (PTK) with over-expression of c-kit was analyzed also by ELISA. The antitumor activity of ethanolic extraction of Leathesia nana (EELN) was evaluated on S₁₈₀-bearing mice. All compounds showed very potent cytotoxicity against all of the eight cancer cell lines with IC₅₀ below 10 μg/mL. In PTK inhibition study, all bromophenol derivatives showed moderate inhibitory activity and compounds 2, 5 and 6 showed significant bioactivity with the inhibition ratio of 77.5%, 80.1% and 71.4%, respectively. Pharmacological studies reveal that EELN could inhibit the growth of Sarcoma 180 tumor and increase the indices of thymus and spleen to improve the immune system remarkably in vivo. Results indicated that the bromophenol derivatives and EELN can be used as potent antitumor agents for PTK over-expression of c-kit and considered in a new therapeutic strategy for treatment of cancer. Supported by the National High Technology Research and Development Program of China (863 Program, No. 2007AA09Z410) and Knowledge Innovation Program of Chinese Academy of Sciences (No. KZCX2-YW-209)